{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T19:27:01Z","timestamp":1765826821695,"version":"3.44.0"},"reference-count":25,"publisher":"BMJ","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pathol"],"published-print":{"date-parts":[[1995,3]]},"abstract":"<jats:p>AIM--To investigate the avidity of specific IgG polyribosyl ribitol phosphate (PRP) antibodies induced by three Haemophilus influenzae type b (Hib) conjugate vaccines: PRP-meningococcal outer membrane protein complex (PRP-OMP), PRP-non-toxic mutant diphtheria toxin, CRM197 (HbOC) and PRP-tetanus toxoid (PRP-T). METHODS--One hundred and ten infants were immunised with one of the vaccines at two, three and four months of age. Blood samples were taken after each vaccination and serum stored at -20 degrees C. Serum samples collected after the third course (that is, at five months of age) were submitted to antibody avidity assessment, using a urea enzyme linked immunosorbent assay (ELISA). RESULTS--All three conjugate vaccines elicited IgG PRP antibodies of high median avidity. The resultant antibody populations were heterogeneous with regard to avidity, which in turn was independent of PRP antibody concentration. CONCLUSIONS--With the recent findings of a correlation between bactericidal killing and affinity, our data highlight the need for a protective level to be expressed qualitatively as well as quantitatively.<\/jats:p>","DOI":"10.1136\/jcp.48.3.206","type":"journal-article","created":{"date-parts":[[2007,6,9]],"date-time":"2007-06-09T00:50:46Z","timestamp":1181350246000},"page":"206-209","source":"Crossref","is-referenced-by-count":15,"title":["Avidity of specific IgG antibodies elicited by immunisation against Haemophilus influenzae type b."],"prefix":"10.1136","volume":"48","author":[{"given":"A E","family":"Agbarakwe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Begg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H M","family":"Chapel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[1995,3,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0022-3476(79)80571-5","article-title":"Systemic Haemophilus influenzae disease: an overview","volume":"94","author":"Dajani, A.S.; I, Asmar B.; Thirumoorrthi, M.C.","year":"1979","unstructured":"Dajani AS, Asmar B I, Thirumoorrthi MC. Systemic Haemophilus influenzae disease: an overview. Pediatr 1979;94:355-64.","journal-title":"Pediatr"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/adc.64.4.517","article-title":"Haemophilus influenzae type b disease in the Oxford region","volume":"64","author":"Tudor-Williams, G.; Frankland, J.; Di, Isaacs; Mayon-White, R.T.; Macfarlane, J.A.; Slack, M.P.E.","year":"1989","unstructured":"Tudor-Williams G, Frankland J, Isaacs Di, Mayon-White RT, Macfarlane JA, Slack MPE, et al. Haemophilus influenzae type b disease in the Oxford region. Arch Dis Child 1989;64:517-19.","journal-title":"Arch Dis Child"},{"key":"ref_3","first-page":"610","article-title":"Immunisation with oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a large health maintenance organisation population: extended follow-up and impact on Haemophilus influenzae disease epidemiology. The Kaiser Permanente Pediatric Vaccine Study Group","volume-title":"Pediatr Infect DisJI","volume":"11","author":"Black, S.B.; Shinefield, H.R.","year":"1992","unstructured":"Black SB, Shinefield HR. Immunisation with oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a large health maintenance organisation population: extended follow-up and impact on Haemophilus influenzae disease epidemiology. The Kaiser Permanente Pediatric Vaccine Study Group. Pediatr Infect DisJI 1992;11:610-13."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0022-3476(05)81786-X","article-title":"Efficacy and safety of a Haemophilus influenzae type b capsular polysaccharide - tetanus protein conjugate vaccine","volume":"121","author":"Fritzell, B.; Plotkin, S.","year":"1992","unstructured":"Fritzell B, Plotkin S. Efficacy and safety of a Haemophilus influenzae type b capsular polysaccharide - tetanus protein conjugate vaccine. Jf Pediatr 1992;121:355-62.","journal-title":"Jf Pediatr"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0022-3476(88)80684-X","article-title":"Clinical and immunological responses to the capsular polysaccharide of Haemophilus influenzae type b alone or conjugated to tetanus toxoid in 18-to 23-month-old children","volume":"112","author":"Claesson, B.A.; Trollfors, B.; Lagergard, T.; Taranger, J.; Bryla, D.; Otterman, G.","year":"1988","unstructured":"Claesson BA, Trollfors B, Lagergard T, Taranger J, Bryla D, Otterman G, et al. Clinical and immunological responses to the capsular polysaccharide of Haemophilus influenzae type b alone or conjugated to tetanus toxoid in 18-to 23-month-old children. Jf Pediatr 1988;112: 695-702.","journal-title":"Jf Pediatr"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0022-3476(05)81186-2","article-title":"Differences in the immunogenecity of three Haemophilus influenzae type b conjugate vaccines in infants","volume":"121","author":"Granoff, D.M.; Anderson, E.L.; Osterholm, M.T.; Holmes, S.J.; McHugh, J.E.; Helshie, R.B.","year":"1992","unstructured":"Granoff DM, Anderson EL, Osterholm MT, Holmes SJ, McHugh JE, Helshie RB, et al. Differences in the immunogenecity of three Haemophilus influenzae type b conjugate vaccines in infants. J Pediatr 1992;121: 187-94.","journal-title":"J Pediatr"},{"key":"ref_7","first-page":"1","article-title":"and efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b vaccine in a United States population: possible implications for optimal use","volume":"165","author":"Black, S.B.; Shinefield, H.R.; Fireman, B.; Safety, Hiatt R.; inmmunogenicity","year":"1992","unstructured":"Black SB, Shinefield HR, Fireman B, Hiatt R. Safety, inmmunogenicity, and efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b vaccine in a United States population: possible implications for optimal use. J Infect Dis 1992;165(Supp 1):S139-43.","journal-title":"J Infect Dis"},{"key":"ref_8","first-page":"1184","article-title":"Antibody levels achieved in infants by course of Haemophilus influenzae type b polysaccharide\/ diphtheria toxoid conjugate vaccine","volume":"i:","author":"Eskola, J.; Kayhty, H.; Peltola, H.; Karanko, V.; Makela, P.H.; Samuelson, J.","year":"1985","unstructured":"Eskola J, Kayhty H, Peltola H, Karanko V, Makela PH, Samuelson J, et al. Antibody levels achieved in infants by course of Haemophilus influenzae type b polysaccharide\/ diphtheria toxoid conjugate vaccine. Lancet 1985;i: 1184-6.","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0022-3476(89)80611-0","article-title":"Protective levels of serum antibodies stimulated in infants by two injections of Haemophilus influenzae type b capsular polysaccharide tetanus toxoid conjugate","volume":"114","author":"Claesson, B.A.; Scheerson, R.; Robbins, J.B.; Johansson, J.; Lagergard, T.; Taranger, J.","year":"1989","unstructured":"Claesson BA, Scheerson R, Robbins JB, Johansson J, Lagergard T, Taranger J, et al. Protective levels of serum antibodies stimulated in infants by two injections of Haemophilus influenzae type b capsular polysaccharide tetanus toxoid conjugate. Jf Pediatr 1989;114:97-100.","journal-title":"Jf Pediatr"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/infdis\/149.6.1034","article-title":"The protective level of serum antibodies to the capsular polysaccharide of Hib","volume":"149","author":"Anderson, P.","year":"1984","unstructured":"Anderson P. The protective level of serum antibodies to the capsular polysaccharide of Hib [letter]. Jf Infect Dis 1984; 149:1034.","journal-title":"Jf Infect Dis"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/infdis\/162.5.1185","article-title":"Antibody affinity in infants after immunisation with conjugated capsular polysaccharide from Haemophilus influenzae type b","volume":"162","author":"Hetherington, S.V.; Rutkowski","year":"1990","unstructured":"Hetherington SV, Rutkowski. Antibody affinity in infants after immunisation with conjugated capsular polysaccharide from Haemophilus influenzae type b. J Infect Dis 1990;162:1185-8.","journal-title":"J Infect Dis"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/infdis\/165.4.753","article-title":"Correlation between antibody affinity and serum bactericidal activity in infants","volume":"165","author":"Hetherington, S.V.; Lepow, M.L.","year":"1992","unstructured":"Hetherington SV, Lepow ML. Correlation between antibody affinity and serum bactericidal activity in infants. J Infect Dis 1992;165:753-6.","journal-title":"J Infect Dis"},{"key":"ref_13","article-title":"Antibody affinity, thermodynamic aspects and biological significance","volume-title":"Boco","author":"Steward, M.W.; Steensgaard, J.","year":"1983","unstructured":"Steward MW, Steensgaard J. Antibody affinity, thermodynamic aspects and biological significance. Boco Raton, FL: CRC Press, 1983."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0140-6736(92)90336-2","article-title":"Immunogenicity of combined diphtheria, tetanus and pertussis vaccine given at 2, 3 and 4 months versus 3, 5 and 9 months of age","volume":"339","author":"Booy, R.; Aitken, S.J.M.; Taylor, S.; Tudor-Williams, G.; Macfarlane, J.A.; Moxon, E.R.","year":"1992","unstructured":"Booy R, Aitken SJM, Taylor S, Tudor-Williams G, Macfarlane JA, Moxon ER, et al. Immunogenicity of combined diphtheria, tetanus and pertussis vaccine given at 2, 3 and 4 months versus 3, 5 and 9 months of age. Lancet 1992; 339:507-10.","journal-title":"Lancet"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/infdis\/159.4.736","article-title":"Recent primary toxoplasma infection indicated by a low avidity of specific IgG","volume":"159","year":"1989","unstructured":"Hedman K, Lappalainen M, Seppaia I, Makela 0. Recent primary toxoplasma infection indicated by a low avidity of specific IgG. Jf Infect Dis 1989;159:736-40.","journal-title":"Jf Infect Dis"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0022-1759(79)90340-5","article-title":"ELISA methodology for polysaccharide antigens: protein coupling of polysaccharides for adsorption to plastic tubes","volume":"28","author":"Gray, B.M.","year":"1979","unstructured":"Gray BM. ELISA methodology for polysaccharide antigens: protein coupling of polysaccharides for adsorption to plastic tubes. J Immunol Methods 1979;28:187-92.","journal-title":"J Immunol Methods"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1136\/jcp.43.12.1032","article-title":"Potential role of IgG avidity for diagnosing toxoplasmosis","volume":"43","author":"Joynson, D.H.M.; Payne, R.A.; Rawal, B.K.","year":"1990","unstructured":"Joynson DHM, Payne RA, Rawal BK. Potential role of IgG avidity for diagnosing toxoplasmosis. J Clin Pathol 1990; 43:1032-3.","journal-title":"J Clin Pathol"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/infdis\/147.6.1100","article-title":"The protective level of serum antibodies to the capsular polysaccharide of Hib","volume":"147","author":"Kayhty, H.; Peltola, H.; Karanko, V.; Makela, P.M.","year":"1983","unstructured":"Kayhty H, Peltola H, Karanko V, Makela PM. The protective level of serum antibodies to the capsular polysaccharide of Hib. J Infect Dis 1983;147: 1100.","journal-title":"J Infect Dis"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0022-3476(89)80432-9","article-title":"Immunogenicity of Haemophilus influenzae type b polysaccharide-outer membrane protein conjugate vaccine in patients who acquired Haemophilus disease despite previous vaccination with type b polysaccharide vaccine","volume":"114","author":"Granoff, D.M.; Chacko, A.; Lottenbach, K.R.; Sheetz, K.E.","year":"1989","unstructured":"Granoff DM, Chacko A, Lottenbach KR, Sheetz KE. Immunogenicity of Haemophilus influenzae type b polysaccharide-outer membrane protein conjugate vaccine in patients who acquired Haemophilus disease despite previous vaccination with type b polysaccharide vaccine. J Pediatr 1989;114:925-33.","journal-title":"J Pediatr"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/infdis\/148.4.767","article-title":"Class-specific antibody response to Haemophilus influenzae type b capsular polysaccharide vaccine","volume":"148","author":"Kayhty, H.; Schneerson, R.; Sutton, A.","year":"1983","unstructured":"Kayhty H, Schneerson R, Sutton A. Class-specific antibody response to Haemophilus influenzae type b capsular polysaccharide vaccine. Jf Infect Dis 1983;148:767.","journal-title":"Jf Infect Dis"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1172\/JCI114548","article-title":"A major cross reactive idiotype associated with human antibodies to the Haemophilus influenzae b polysaccharide","volume":"85","author":"Lucas, A.H.; Granoff, D.M.","year":"1990","unstructured":"Lucas AH, Granoff DM. A major cross reactive idiotype associated with human antibodies to the Haemophilus influenzae b polysaccharide. Jf Clin Invest 1990;85:1158-66.","journal-title":"Jf Clin Invest"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1001\/jama.1992.03480110065035","article-title":"DM and the vaccine study group. Avidity and bactericidal activity of antibody elicited by different Hib conjugate vaccines","volume":"267","author":"Schlesinger, Y.; Granoff","year":"1992","unstructured":"Schlesinger Y, Granoff DM and the vaccine study group. Avidity and bactericidal activity of antibody elicited by different Hib conjugate vaccines. JAAMA 1992;267:1489-94.","journal-title":"JAAMA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0022-1759(85)90074-2","article-title":"The importance of antibody affinity in the performance of immunoassays for antibody","volume":"78","author":"Steward, M.W.; Lew, A.M.","year":"1985","unstructured":"Steward MW, Lew AM. The importance of antibody affinity in the performance of immunoassays for antibody. 7 Immunol Methods 1985;78:173-90.","journal-title":"7 Immunol Methods"},{"key":"ref_24","first-page":"215","article-title":"Review. Anti-DNA antibodies: problems in their study and interpretation. Clin Exp Immunol","volume":"65","author":"Eilat, D.","year":"1986","unstructured":"Eilat D. Review. Anti-DNA antibodies: problems in their study and interpretation. Clin Exp Immunol 1986;65:215-22."},{"article-title":"Immunological aspects of rheumatlogy","author":"Steward, M.W.","key":"ref_25","unstructured":"Steward MW, Devey ME. In: Dick WC, ed. Immunological aspects of rheumatlogy, Lancaster: MTP Press, 1987:63-"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jcp.48.3.206","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T16:01:02Z","timestamp":1758816062000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jcp.48.3.206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,3]]},"references-count":25,"journal-issue":{"issue":"3","published-online":{"date-parts":[[1995,3,1]]},"published-print":{"date-parts":[[1995,3]]}},"alternative-id":["10.1136\/jcp.48.3.206"],"URL":"https:\/\/doi.org\/10.1136\/jcp.48.3.206","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"type":"print","value":"0021-9746"},{"type":"electronic","value":"1472-4146"}],"subject":[],"published":{"date-parts":[[1995,3]]}}}